Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas

Evelyn de Groot(The University of Texas MD Anderson Cancer Center), Y.N. Vashisht Gopal(AstraZeneca (United Kingdom))

Cancer & Metabolism

February 22, 2022

10.1186/s40170-022-00281-0

Cited by 26

Related Papers

Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in <i>Braf-</i> Mutant Human Cutaneous Melanoma Cells

|Cancer Research|2010|230